How we innovate
Backed by an annual research and development investment of €1.5 billion and about 23,000 technical intellectual property rights, including more than 14,000 granted patents, we constantly bring breakthrough innovations to market – for the benefit of patients, medical professionals, and society. Here's how we do that.
Innovation is in our DNA. In my opinion it is a process driven by interdisciplinary collaboration and dialogue. However, it only acquires value and significance when it is made useful to people.
Peter Schardt, CTO Siemens Healthineers
Driving the digital transformation of healthcare
We’re currently focusing on innovative solutions for:
Cardiology
Innovating for impact
No matter how digitally enhanced the practice of medicine will be, in the end patients won’t look for platforms, but for outcomes which really matter to them. Value is created by early and correct diagnosis. Value is created by treating as effectively and as individually as possible. That is why we focus on precision medicine.
Peter Schardt, CTO Siemens Healthineers
People are key
Hear from our R&D team what motivates them to drive innovation around AI
Collaboration is key
Global infrastructures like the Innovation Think Tank are crucial to drive innovation in a complex and diverse healthcare domain across various regions. It is the right place where ideas, technology, and clinical expertise can meet, be exchanged, and eventually merge. The collaboration with top medical institutions around the world allows us to develop a clear picture for clinical indications and their need for innovative solutions.
Peter Schardt, CTO Siemens Healthineers
AdvaMedDX, “A Policy Primer on Diagnostics”, June 2011, p. 3.